Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
alliance, ampreloxetine, ApiJect, BATURA, Blueprint, BR, bronchoconstriction, decentralized, diagnosed, embedded, exacerbation, extend, extended, focused, Gavreto, Innoviva, intention, iodine, ipilimumab, LLP, lump, maintenance, mantle, merger, mg, nasal, nivolumab, notified, proposed, RAINBOWFISH, randomized, Respiratory, resume, role, scale, SHINE, sitting, spray, standing, stepped, Theravance, Trelegy, walking
Removed:
achieve, authorized, award, bankrupt, bankruptcy, bear, Canadian, Central, CLL, compute, computed, concurrently, counsel, CRPC, demand, dollar, driver, ensure, entering, estate, Euro, examination, executed, external, feasibly, fluctuation, formulation, Franc, fulfillment, functional, indirect, local, lock, main, manage, managed, maximize, MDD, minimal, obtaining, operate, PH, precedent, preservation, proceeding, quantum, regularly, reimbursement, representing, residual, Sanofi, sBLA, sensitivity, short, SLL, speculative, structured, subsequently, targeted, team, test, transactional, ultimate, utilize, Yen
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view